-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

Dow Jones·03/23/2026 12:30:00

Please log in to view news